Outbreak of Multi-Drug Resistant Pseudomonas aeruginosa Bloodstream Infection in the Haematology Unit of a South African Academic Hospital

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Mudau, Maanda ^a,c,d   Jacobson, Rachael ^a   Minenza, Nadia ^b   Kuonza, Lazarus ^c,d   Morris, Vida ^e   Engelbrecht, Heather ^e   Nicol, Mark P ^a,b   Bamford, Colleen ^a,b  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Field Epidemiology and Laboratory Training Programme   (South Africa)

^d UNIVERSITY OF PRETORIA   (South Africa)

^e WESTERN CAPE DEPARTMENT OF HEALTH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFECTION CONTROL; INFECTION RISK; MALE; MEDICAL RECORD REVIEW; MOLECULAR TYPING; MORTALITY; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SCREENING TEST; SOUTH AFRICA;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; BACTEREMIA; CASE-CONTROL STUDIES; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITAL UNITS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; YOUNG ADULT;

EID: 84875033208     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055985     Document Type: Review

References (29)

1. Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, et al. (2011) Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 377: 228-241.
2. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, et al. (2005) Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 5: 481-493.
3. Hancock RE, Speert DP, (2000) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. Drug Resist Updat 3: 247-255.
4. Lambert PA, (2002) Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. J R Soc Med 95 Suppl 41: 22-26.
5. Harris AD, Perencevich E, Roghmann MC, Morris G, Kaye KS, et al. (2002) Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients. Antimicrob Agents Chemother 46: 854-858.
6. Joo EJ, Kang CI, Ha YE, Kim J, Kang SJ, et al. (2011) Clinical predictors of Pseudomonas aeruginosa bacteremia among Gram-negative bacterial infections in non-neutropenic patients with solid tumor. J Infect 63: 207-214.
7. Clinical and Laboratory Standards Institute (2010) Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Wayne, Pennsylvania.
8. National Health Laboratory Service Standard Operating Procedure MIC1605v1 (2011) Testing for pathogens in water by membrane filtration method.
9. PulseNetInternational. Available: http://www.pulsenetinternational.org/SiteCollectionDocuments/pfge/5%201_5%202_5%204_PNetStand_Ecoli_with_Sflexneri.pdf. Accessed 2011 Dec 13.
10. Tenover F, Arbeit R, Goering R, Mickelsen P, Murray B, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
11. Curran B, Jonas D, Grundmann H, Pitt T, Dowson C, (2004) Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 42: 5644-5649.
12. Jacobson R, Minenza N, Bamford C, Nicol M, (2012) VIM-2 metallo-beta-lactamase-producing Pseudomonas aeruginosa causing an outbreak in South Africa. J Antimicrob Chemother 67: 1797-8.
13. Tsutsui A, Suzuki S, Yamane K, Matsui M, Konda T, et al. (2011) Genotypes and infection sites in an outbreak of multidrug-resistant Pseudomonas aeruginosa. J Hosp Infect 78: 317-322.
14. Samuelsen Ø, Toleman M, Sundsfjord A, Rydberg J, Leegaard T, et al. (2010) Molecular epidemiology of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother 54: 346-352.
15. Tancrede CH, Andremont AO, (1985) Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J Infect Dis 152: 99-103.
16. Mayank D, Anshuman M, Singh RK, Afzal A, Baronia AK, et al. (2009) Nosocomial cross-transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit. Indian J Pathol Microbiol 52: 509-513.
17. Kominos SD, Copeland CE, Grosiak B, (1972) Mode of transmission of Pseudomonas aeruginosa in a burn unit and an intensive care unit in a general hospital. Appl Microbiol 23: 309-312.
18. Widmer AF, Wenzel RP, Trilla A, Bale MJ, Jones RN, et al. (1993) Outbreak of Pseudomonas aeruginosa infections in a surgical intensive care unit: probable transmission via hands of a health care worker. Clin Infect Dis 16: 372-376.
19. Harris A, Samore M, Lipsitch M, Kaye K, Perencevich E, et al. (2002) Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli. Clin Infect Dis 34: 1558-63.
20. Cortes JA, Cuervo SI, Urdaneta AM, Potdevin G, Arroyo P, et al. (2009) Identifying and controlling a multiresistant Pseudomonas aeruginosa outbreak in a Latin-American cancer centre and its associated risk factors. Braz J Infect Dis 13: 99-103.
21. Micol JB, de Botton S, Guieze R, Coiteux V, Darre S, et al. (2006) An 18-case outbreak of drug-resistant Pseudomonas aeruginosa bacteraemia in hematology patients. Haematologica 91: 1134-1138.
22. Engelhart S, Krizek L, Glasmacher A, Fischnaller E, Marklein G, et al. (2002) Pseudomonas aeruginosa outbreak in a haematology-oncology unit associated with contaminated surface cleaning equipment. J Hosp Infect 52: 93-98.
23. Schimpff S, Satterlee W, Young VM, Serpick A, (1971) Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 284: 1061-1065.
24. Schimpff SC, (1986) Empiric antibiotic therapy for granulocytopenic cancer patients. Am J Med 80: 13-20.
25. Klastersky J, (2000) Empirical treatment of sepsis in neutropenic patients. Int J Antimicrob Agents 16: 131-133.
26. Pitout JD, Revathi G, Chow BL, Kabera B, Kariuki S, et al. (2008) Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya. Clin Microbiol Infect 14: 755-759.
27. Hammami S, Boutiba-Ben Boubaker I, Ghozzi R, Saidani M, Amine S, et al. (2011) Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-beta-lactamase in a kidney transplantation unit. Diagn Pathol 6: 106.
28. Crespo MP, Woodford N, Sinclair A, Kaufmann ME, Turton J, et al. (2004) Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbiol 42: 5094-5101.
29. Poirel L, Weldhagen GF, De Champs C, Nordmann P, (2002) A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum beta-lactamase GES-2 in South Africa. J Antimicrob Chemother 49: 561-565.